Search
Tony Keating says he is excited about receiving first regulatory approval for its flagship acute diagnostic product.

ResApp shares spike on EU green light

Shares in digital health company ResApp Health have closed up 33 per cent today to 20 cents, after it received European regulatory approval for its first commercial product – the ResAppDx-EU.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Source: Morningstar

Total Shareholder Return as at 30/08/19

1 year TSR5 year TSR
250thProteomics International Laboratories15%
274thResApp Health10%98%
312thAlterra2%10%
602ndOBJ-38%-31%
736 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

05/10/17
$65k Bought
16/12/16
$49k Bought
16/12/16
$49k Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

103rd↑Alterra$2.9m
104th↑Ephraim Resources$2.9m
105th↑ResApp Health$2.7m
106th↑OBJ$2.7m
107th↑Proteomics International Laboratories$2.7m
197 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer